m6A methylation modification: Potential pathways to suppress osteosarcoma metastasis
International Immunopharmacology · 2025-01 · 145 · 113759
DOI: 10.1016/j.intimp.2024.113759 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2025-01. Verfasst von Tianrui Hu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Spine Surgery, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, China. Hauptthemen laut MEDLINE: Bone Neoplasms, Osteosarcoma. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Osteosarcoma is a highly aggressive malignant bone tumor prone to metastasis, and its metastatic process is one of the main reasons for treatment failure and poor prognosis. Recent studies have demonstrated that modification of m6A methylation plays an important role in osteosarcoma metastasis, influencing both invasion and metastasis through various signaling pathways. Therefore, clarification of the specific effects of m6A methylation modification in osteosarcoma may reveal ways to improve the prognosis of osteosarcoma patients. The roles of various components involved in the m6A methylation modification process in osteosarcoma have been investigated, with studies focusing more on their effects than on their mechanisms. In this review, we focus on the interactions between the "writers," "erasers," and "readers" of m6A methylation and tumor metastasis-related factors to enhance the understanding of osteosarcoma and m6A methylation modification, with the aim of identifying clinical diagnostic biomarkers and potential therapeutic targets for osteosarcoma metastasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Spine Surgery, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, China.
- Department of Spine Surgery, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, China. Electronic address: drywdeng@csu.edu.cn.
- Department of Spine Surgery, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, China. Electronic address: xywwg1978@163.com.
Zitieren
APA
Hu, T., Wang, G., Wang, D., Deng, Y., & Wang, W. (2025). m6A methylation modification: Potential pathways to suppress osteosarcoma metastasis. International Immunopharmacology, 145, 113759. https://doi.org/10.1016/j.intimp.2024.113759
Vancouver
Hu T, Wang G, Wang D, Deng Y, Wang W. m6A methylation modification: Potential pathways to suppress osteosarcoma metastasis. International Immunopharmacology. 2025;145:113759. doi:10.1016/j.intimp.2024.113759
BibTeX
@article{Hu2025,
author = {Hu, Tianrui and Wang, Guowei and Wang, Dong and Deng, Youwen and Wang, Weiguo},
title = {m6A methylation modification: Potential pathways to suppress osteosarcoma metastasis},
journal = {International Immunopharmacology},
year = {2025},
volume = {145},
pages = {113759},
doi = {10.1016/j.intimp.2024.113759}
}
EUVIMED